Clinicians want to implant those patients with cardiac resynchronization therapy (CRT) who can benefit from it in terms of quality of life, symptoms, and survival. Still, selection of these patients is not straight forward. We are continuously trying to improve the treatment by looking for new techniques, new parameters, new indices, to select the correct patients, to select the correct lead position and pacing site(s), to select the correct device programming and to select the correct response parameters. Among a myriad of response parameters to CRT, the reduction of end-systolic volume (ESV) is widely in use and has been used in several trials.1,2
from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2xi2Qdi
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,